UBS Group’s Nova Vision Acquisition Corp. Rights NOVVR Stock Holding History

UBS Group’s Portfolio NOVVR Stock Details NOVVR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-905	Closed	-$222	–	10810
2024 Q3	$222	Sell	905 -5,522	-86%	-$1.35K	﹤0.01%	9053
2024 Q2	$1.03K	Buy	+6,427	New	+$1.14K	﹤0.01%	8684
2023 Q2	–	Sell	-2,100	Closed	-$504	–	10443
2023 Q1	$504	Sell	2,100 -500	-19%	-$89	﹤0.01%	9004
2022 Q4	$156	Buy	2,600 +2,500	+2,500%	+$297	﹤0.01%	10345
2022 Q3	$0	Buy	+100	New	+$12	﹤0.01%	11853

UBS Group's NOVVR Position: Q4 2024 in Review

UBS Group sold out of Nova Vision Acquisition Corp. Rights (NOVVR) in Q4 2024, closing a stake of 905 shares — an estimated $222 sold.

UBS Group first reported a position in NOVVR in Q3 2022 and held it in 5 quarters. The position peaked at $1.03K in Q2 2024. 0 funds tracked by Wall St. Rank hold NOVVR as of Q4 2024.

UBS Group reported no remaining Nova Vision Acquisition Corp. Rights position as of Q4 2024 after selling out during the quarter.
UBS Group sold 905 Nova Vision Acquisition Corp. Rights shares in Q4 2024, an estimated $222.
UBS Group first reported a position in Nova Vision Acquisition Corp. Rights in Q3 2022 and held it in 5 quarters.
UBS Group's Nova Vision Acquisition Corp. Rights position peaked at $1.03K in Q2 2024.
0 funds tracked by Wall St. Rank held Nova Vision Acquisition Corp. Rights as of Q4 2024.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.